NATERA, INC. Financing Receivable, Allowance for Credit Loss
NATERA, INC. (NTRA) had Financing Receivable, Allowance for Credit Loss of $6.53 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets
us-gaap:FinancingReceivableAllowanceForCreditLosses · last filed 2026-08-07
- 2026-06-30: Financing Receivable, Allowance for Credit Loss $6.53M.
- 2026-03-31: Financing Receivable, Allowance for Credit Loss $7.93M.
- 2025-12-31: Financing Receivable, Allowance for Credit Loss $8.02M.
- 2025-09-30: Financing Receivable, Allowance for Credit Loss $8.42M.
| Period end | Financing Receivable, Allowance for Credit Loss |
|---|---|
| 2026-06-30 | $6.53M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $7.93M 10-Q · filed 2026-08-07 |
| 2025-12-31 | $8.02M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $8.42M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $7.82M 10-Q · filed 2026-08-07 |
| 2025-03-31 | $7.43M 10-Q · filed 2026-08-07 |
| 2024-12-31 | $7.26M 10-Q · filed 2026-08-07 |
| 2024-09-30 | $6.25M 10-Q · filed 2025-11-07 |
| 2024-06-30 | $7.02M 10-Q · filed 2025-11-07 |
| 2024-03-31 | $7.25M 10-Q · filed 2025-08-08 |
| 2023-12-31 | $6.48M 10-Q · filed 2025-11-07 |
| 2023-09-30 | $6.03M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $5.58M 10-Q · filed 2024-11-12 |
| 2023-03-31 | $5.13M 10-Q · filed 2024-08-09 |
| 2022-12-31 | $3.83M 10-Q · filed 2024-11-12 |
| 2022-09-30 | $4.68M 10-Q · filed 2023-11-09 |
| 2022-06-30 | $3.56M 10-Q · filed 2023-11-09 |
| 2022-03-31 | $2.39M 10-Q · filed 2023-08-04 |
| 2021-12-31 | $2.43M 10-Q · filed 2023-11-09 |
| 2021-09-30 | $4.11M 10-Q · filed 2022-11-09 |
| 2021-06-30 | $3.79M 10-Q · filed 2022-11-09 |
| 2021-03-31 | $4.11M 10-Q · filed 2022-08-05 |
| 2020-12-31 | $4.22M 10-Q · filed 2022-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |